IP Verse

Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof

Patent No. EP4357457 (titled "Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof") was filed by Toolgen Incorporated on Oct 23, 2013. The application was issued on Oct 16, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GRUND GROUP PATENTANWALTE UND SOLICITOR PARTG MBBMar 6, 2025GRUND
VERTEX PHARMACEUTICALS INCORPORATEDFeb 28, 2025CARPMAELS & RANSFORD
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBOct 16, 2024-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4357457

TOOLGEN INCORPORATED
Application Number
EP24158339A
Filing Date
Oct 23, 2013
Status
Granted And Under Opposition
Sep 13, 2024
Publication Date
Oct 16, 2024
External Links
Slate, Register , Google Patents